In normal mice, a mitochondrially-targeted catalase (MCAT) suppresses Bak expression in the cochlea, thereby reducing DNA damage associated with oxidative stress, and delaying the onset of age-related hearing loss (AHL). Here, BAK1 is linked to acute hemorrhagic leukoencephalitis.